Related Experiment Video
Updated: May 10, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Increased expression of STK25 leads to impaired glucose utilization and insulin sensitivity in mice challenged with a
Emmelie Cansby1, Manoj Amrutkar, Louise Mannerås Holm
1The Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, University of Gothenburg, Blå stråket 5, SE-41345 Gothenburg, Sweden.
Abstract:
Partial depletion of serine/threonine protein kinase 25 (STK25), a member of the Ste20 superfamily of kinases, increases lipid oxidation and glucose uptake in rodent myoblasts. Here we show that transgenic mice overexpressing STK25, when challenged with a high-fat diet, develop reduced glucose tolerance and insulin sensitivity compared to wild-type siblings, as evidenced by impairment in glucose and insulin tolerance tests as well as in euglycemic-hyperinsulinemic clamp studies. The fasting plasma insulin concentration was elevated in Stk25 transgenic mice compared to wild-type littermates (4.9±0.8 vs. 2.6±0.4 ng/ml after 17 wk on high-fat diet, P<0.05). Overexpression of STK25 decreased energy expenditure during the dark phase of observation (P<0.05), despite increased spontaneous activity. The oxidative capacity of skeletal muscle of transgenic carriers was reduced, as evidenced by altered expression of Cpt1, Acox1, and ACC. Hepatic triglycerides and glycogen were elevated (1.6- and 1.4-fold, respectively; P<0.05) and expression of key enzymes regulating lipogenesis (Fasn), glycogen synthesis (Gck), and gluconeogenesis (G6pc, Fbp1) was increased in the liver of the transgenic mice. Our findings suggest that overexpression of STK25 in conditions of excess dietary fuels associates with a shift in the metabolic balance in peripheral tissues from lipid oxidation to storage, leading to a systemic insulin resistance.
Insights
Overexpression of serine/threonine protein kinase 25 (STK25) impairs glucose tolerance and insulin sensitivity. This metabolic shift promotes lipid storage over oxidation, contributing to systemic insulin resistance, particularly under high-fat diet conditions.
Area of Science:
- Metabolic regulation
- Molecular biology
- Physiology
Background:
- Serine/threonine protein kinase 25 (STK25) is a Ste20 superfamily kinase.
- Partial STK25 depletion enhances lipid oxidation and glucose uptake in myoblasts.
Purpose of the Study:
- To investigate the role of STK25 overexpression in metabolic dysfunction.
- To determine the impact of STK25 on glucose tolerance and insulin sensitivity in vivo.
Main Methods:
- Generation of STK25 transgenic mice.
- High-fat diet challenge.
- Glucose and insulin tolerance tests.
- Euglycemic-hyperinsulinemic clamp studies.
- Analysis of gene expression in skeletal muscle and liver.
Main Results:
- STK25 transgenic mice exhibited reduced glucose tolerance and insulin sensitivity.
- Fasting plasma insulin levels were elevated in transgenic mice.
- Energy expenditure decreased, while hepatic lipid and glycogen stores increased.
- Skeletal muscle oxidative capacity was diminished, with altered expression of key metabolic enzymes.
Conclusions:
- Overexpression of STK25 promotes a metabolic shift towards lipid storage and away from oxidation.
- This shift contributes to systemic insulin resistance, especially under conditions of excess dietary fuel.
- STK25 plays a critical role in regulating metabolic balance and insulin sensitivity.
Related Concept Videos
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Cell Specific Gene Expression

